LISATA THERAPEUTICS, INC. — Director's Dealing 2011

Mar 4, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2011-03-03

Reporting Person: Pecora Andrew L (See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-03-03	Common Stock, par value $0.001 per share	P	78125	$1.28	Acquired	1922652	Direct

Footnotes

F1: The reporting person participated in a private placement of NeoStem, Inc. (the "Company") common stock due to restrictions on
his purchasing the Company's common stock in the open market and in response to his desire to increase his ownership in the
Company. The shares of common stock were purchased at the then market price of the common stock of the Company under a
subscription agreement entered into on February 25, 2011.